Anyakora, Chimezie
Ekwunife, Obinna
Alozie, Faith
Esuga, Mopa
Ukwuru, Jonathan
Onya, Steve
Nwokike, Jude
Funding for this research was provided by:
United States Agency for International Development
Article History
Received: 24 June 2017
Accepted: 8 September 2017
First Online: 18 September 2017
Authors’ information
: CA is the chief of party in Nigeria for the Promoting the Quality of Medicines Program (PQM), U.S. Pharmacopeial Convention. OE is a senior lecturer in department of Clinical Pharmacy, Nnamdi Azikiwe University. FA is affiliated with the Centre for Applied Research on Separation Science, Lagos. ME and JU are staff of the the Promoting the Quality of Medicines Program (PQM), U.S. Pharmacopeial Convention. SO is the Managing Director of Chi Pharmaceutical Limited, Nigeria. JN is the Director of the Promoting the Quality of Medicines Program (PQM), U.S. Pharmacopeial Convention.
: Not applicable because the study does not involve any human subject or animals.
: Consent to publish data obtained from Chi Pharmaceutial Limited was obtained from the company’s Managing Director, Mr. Steve Onya.
: OE and SO have no competing interests. CA, JN, ME, JU are employees of the project– Promoting the Quality of Medicines Program (PQM), U.S. Pharmacopeial Convention.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.